Molecular classification of the PORTEC-3 trial for high-risk endometrial cancer: impact on prognosis and benefit from adjuvant therapy

et al., TransPORTEC consortium

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Molecular classification of the PORTEC-3 trial for high-risk endometrial cancer: impact on prognosis and benefit from adjuvant therapy'. Together they form a unique fingerprint.

Medicine and Dentistry

Immunology and Microbiology